BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 286107)

  • 1. Role of antibodies in the specificity of natural cell-mediated cytotoxicity.
    Takasugi M; Akira D
    J Natl Cancer Inst; 1979 Jun; 62(6):1361-5. PubMed ID: 286107
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reconstitution of natural cell-mediated cytotoxicity with specific antibodies.
    Takasugi J; Koide Y; Takasugi M
    Eur J Immunol; 1977 Dec; 7(12):887-92. PubMed ID: 75804
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Determination of specificity in natural cell-mediated cytotoxicity by natural antibodies.
    Koide Y; Takasugi M
    J Natl Cancer Inst; 1977 Oct; 59(4):1099-105. PubMed ID: 20513
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Search for specificity in natural cell-mediated cytotoxicity.
    Takasugi M; Hardiwidjaja M; McAllister R; Peer M
    J Natl Cancer Inst; 1979 Dec; 63(6):1299-304. PubMed ID: 92584
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Natural and antibody-dependent cell-mediate cytotoxicity to cultured target cells superinfected with Epstein-Barr virus.
    Takasugi M; Mickey MR; Levine PH
    Cancer Res; 1982 Apr; 42(4):1208-14. PubMed ID: 6277480
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antibody-dependent cellular cytotoxicity mediated by murine lymphocytes activated in recombinant interleukin 2.
    Shiloni E; Eisenthal A; Sachs D; Rosenberg SA
    J Immunol; 1987 Mar; 138(6):1992-8. PubMed ID: 3493293
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Loss of specific natural cell-mediated cytotoxicity with absorption of natural antibodies from serum.
    Akira D; Takasugi M
    Int J Cancer; 1977 Jun; 19(6):747-55. PubMed ID: 873640
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evidence that natural cytotoxicity and antibody-dependent cellular cytotoxicity are mediated in humans by the same effector cell populations.
    de Landazuri MO; Silva A; Alvarez J; Herberman RB
    J Immunol; 1979 Jul; 123(1):252-8. PubMed ID: 376742
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Apparent sensitivity of human K lymphocytes to the spatial orientation and organization of target cell-bound antibodies as measured by the efficiency of antibody-dependent cellular cytotoxicity (ADCC).
    Christiaansen JE; Burnside SS; Sears DW
    J Immunol; 1987 Apr; 138(7):2236-43. PubMed ID: 3549899
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human K/natural killer cells targeted with hetero-cross-linked antibodies specifically lyse tumor cells in vitro and prevent tumor growth in vivo.
    Titus JA; Perez P; Kaubisch A; Garrido MA; Segal DM
    J Immunol; 1987 Nov; 139(9):3153-8. PubMed ID: 2959724
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mechanism of defective NK cell activity in patients with acquired immunodeficiency syndrome (AIDS) and AIDS-related complex. II. Normal antibody-dependent cellular cytotoxicity (ADCC) mediated by effector cells defective in natural killer (NK) cytotoxicity.
    Katz JD; Mitsuyasu R; Gottlieb MS; Lebow LT; Bonavida B
    J Immunol; 1987 Jul; 139(1):55-60. PubMed ID: 3584988
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of histamine-receptor blocking on human natural and lectin-dependent cell-mediated cytotoxicity against adherent HEP-2 cells.
    Perl A; Gonzalez-Cabello R; Benedek K; Nékam K; Láng I; Gergely P
    Thymus; 1985; 7(2):111-8. PubMed ID: 4012822
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phorbol esters enhance spontaneous cytotoxicity of human lymphocytes, abrogate Fc receptor expression, and inhibit antibody-dependent lymphocyte-mediated cytotoxicity.
    Trinchieri G; O'Brien T; Shade M; Perussia B
    J Immunol; 1984 Oct; 133(4):1869-77. PubMed ID: 6432902
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Correlation between natural and antibody-dependent cell-mediated cytotoxicity against tumor targets in the mouse. II. Characterization of the effector cells.
    Santoni A; Herberman RB; Holden HT
    J Natl Cancer Inst; 1979 Oct; 63(4):995-1003. PubMed ID: 384012
    [TBL] [Abstract][Full Text] [Related]  

  • 15. GP120 specific cellular cytotoxicity in HIV-1 seropositive individuals. Evidence for circulating CD16+ effector cells armed in vivo with cytophilic antibody.
    Tyler DS; Nastala CL; Stanley SD; Matthews TJ; Lyerly HK; Bolognesi DP; Weinhold KJ
    J Immunol; 1989 Feb; 142(4):1177-82. PubMed ID: 2536767
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Correlation between effector lymphocytes in natural and antibody-mediated cytotoxicity.
    Benczur M; Györffy G; Garam T; Varga M; Medgyesi G; Sándor M; Petranyi GG
    Immunobiology; 1979 Sep; 156(3):320-9. PubMed ID: 540970
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antibody-mediated killing of human tumor cells by attached effector cells.
    Hellström I; Garrigues U; Lavie E; Hellström KE
    Cancer Res; 1988 Feb; 48(3):624-7. PubMed ID: 3335025
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Virus-induced enhancement of lymphocyte-mediated antibody-dependent cytotoxicity (ADCC) in vitro.
    Alsheikhly AR; Wåhlin B; Andersson T; Perlmann P
    J Immunol; 1984 Jun; 132(6):2760-6. PubMed ID: 6373918
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effector cells in human peripheral blood mediating mitogen-induced cellular cytotoxicity and antibody-dependent cellular cytotoxicity.
    Nelson DL; Bundy BM; Pitchon HE; Blaese RM; Strober W
    J Immunol; 1976 Nov; 117(5 Pt 1):1472-81. PubMed ID: 1087314
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mechanism of cell-mediated cytotoxicity at the single cell level. VI. Direct assessment of the cytotoxic potential of human peripheral blood non-lytic effector-target cell conjugates.
    Bonavida B; Lebow LT; Bradley TP
    J Immunol; 1984 Feb; 132(2):594-8. PubMed ID: 6606675
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.